Cleveland BioLabs preclinical data

In a mouse model of neuroblastoma, both oral and IV CBL0137 plus standard chemotherapy - cyclophosphamide and topotecan - led to complete tumor regression in 100% of mice vs. 0% for CBL0137 alone and ...